Literature DB >> 17672849

Measuring symptom occurrence and symptom distress: development of the symptom experience index.

Mei R Fu1, Roxanne W McDaniel, Verna A Rhodes.   

Abstract

AIM: This paper is a report of a study to assess reliability and construct validity of revised and refined version of the Adapted Symptom Distress Scale: the Symptom Experience Index (SEI).
BACKGROUND: The development of the SEI, a 41-item Likert Scale assessing 20 symptoms, was based on self-regulation theory and an integrative conceptual analysis of symptom assessment and management. The model emphasizes the difference between the occurrence of a symptom (or multiple symptoms) and the distress (emotional) response to the occurrence of a symptom. It is the distress from symptom occurrence that promotes a person to take action and use known coping strategies to prevent the symptom occurrence or alleviate the distress from the symptom.
METHOD: A contrast-group and test-retest approach was used to assess construct validity and reliability with a convenience sample of 158 patients at United States of America in 2003-2004.
RESULTS: The SEI demonstrated reasonable internal consistency with a Cronbach's alpha of 0.91 for symptom experience, 0.85 for symptom occurrence and 0.84 for symptom distress. Test-retest reliability was supported by high intra-class correlation coefficients (symptom experience r = 0.93; symptom occurrence r = 0.94; symptom distress, r = 0.92). Construct validity was supported by statistically significant differences between patients and healthy adults.
CONCLUSION: The SEI can be used as a baseline and outcome measure to assess the impact of multiple symptoms on patients, and the effectiveness of interventions to manage these symptoms.

Entities:  

Mesh:

Year:  2007        PMID: 17672849     DOI: 10.1111/j.1365-2648.2007.04335.x

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  4 in total

Review 1.  Use of technology to facilitate a prospective surveillance program for breast cancer-related lymphedema at the Massachusetts General Hospital.

Authors:  Lauren M Havens; Cheryl L Brunelle; Tessa C Gillespie; Madison Bernstein; Loryn K Bucci; Yara W Kassamani; Alphonse G Taghian
Journal:  Mhealth       Date:  2021-01-20

2.  Symptom-monitoring behaviors of rural cancer patients and survivors.

Authors:  Carol J Hermansen-Kobulnicky
Journal:  Support Care Cancer       Date:  2008-12-23       Impact factor: 3.603

3.  The development, usability, and reliability of the Electronic Patient Visit Assessment (ePVA) for head and neck cancer.

Authors:  Janet H Van Cleave; Mei R Fu; Antonia V Bennett; Mark S Persky; Zujun Li; Adam Jacobson; Kenneth S Hu; Allison Most; Catherine Concert; Maria Kamberi; Jacqueline Mojica; Amanda Peyser; Ann Riccobene; Anh Tran; Michael J Persky; Justin Savitski; Eva Liang; Brian L Egleston
Journal:  Mhealth       Date:  2019-07-29

4.  The usefulness of the Electronic Patient Visit Assessment (ePVA)© as a clinical support tool for real-time interventions in head and neck cancer.

Authors:  Janet H Van Cleave; Mei R Fu; Antonia V Bennett; Catherine Concert; Ann Riccobene; Anh Tran; Allison Most; Maria Kamberi; Jacqueline Mojica; Justin Savitski; Elise Kusche; Mark S Persky; Zujun Li; Adam S Jacobson; Kenneth S Hu; Michael J Persky; Eva Liang; Patricia M Corby; Brian L Egleston
Journal:  Mhealth       Date:  2021-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.